Lilly, Incyte rheumatoid arthritis drug succeeds in late-stage study
September 29, 2015 at 07:02 AM EDT
Sept 29 (Reuters) - Eli Lilly and Co and Incyte Corp said a third late-stage study of their experimental rheumatoid arthritis drug met its main goal.